The human oncoprotein MDM2 uses distinct strategies to inhib…

Emerging


10
Citations
0
Refs
2001
Year
Search Works
Work Details
  • DOI 10.3892/ijo.18.3.449
  • PMID https://pubmed.ncbi.nlm.nih.gov/11179471
  • OpenAlex ID W2011292993
  • Type Article
  • Language EN
  • Published 01 Mar 2001
  • Volume 18 (3)
  • Pages 449–59
  • Source International Journal of Oncology
  • Publisher Spandidos Publishing
  • FWCI 0.54
  • Countries 1
  • Institutions 3
  • Added 10 Oct 2025
  • Updated 16 Oct 2026
MENU
0

The human oncoprotein MDM2 uses distinct strategies to inhibit transcriptional activation mediated by the wild-type p53 and its tumor-derived mutants

Article 2001 EN

Human MDM2 (hMDM2) inhibits transcriptional activation mediated by wild-type p53 and its tumor-derived mutants. We present evidence to show that hMDM2 interacts with the tumor-derived mutants of p53 and inhibits transcriptional activation of the human c-myc promoter mediated by the tumor-derived mutants of p53 through two domains. These two domains of hMDM2 are able to function independent of each…

10

Citations

0

References

7

Authors

0.54

FWCI

Citations by Year
Last 3 years
Topics
Keywords
UN Sustainable Development Goals
1 SDGs
Authors & Affiliations
7 authors
#AuthorInstitutionsORCID
1 Doris R. Brown Virginia Commonwealth Universi… (US) VCU Massey Comprehensive Cance… (US) +1
2 Debabrita Deb — —
3 Rebecca A. Frum — —
4 Laura Hickes — —
5 Rubén M. Muñoz — —
6 Sumitra Deb —
7 Swati Palit Deb —

Data: OpenAlex